Stephen K. Burley
Corporate Officer/Principal bij The Rockefeller University
Actieve functies van Stephen K. Burley
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| The Rockefeller University | Corporate Officer/Principal | 01-06-1997 | - |
Loopbaan van Stephen K. Burley
Eerdere bekende functies van Stephen K. Burley
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2002 | 18-04-2011 |
| CASCADIAN THERAPEUTICS INC (USA) | Directeur/Bestuurslid | 09-06-2008 | 04-09-2008 |
Prospect Genomics, Inc.
 Prospect Genomics, Inc. Packaged SoftwareTechnology Services Prospect Genomics, Inc. developed computational technology solutions for the pharmaceutical field. The company was headquartered in San Diego, CA. | Oprichter | 21-12-2009 | - |
| Corporate Officer/Principal | - | 21-12-2009 |
Opleiding van Stephen K. Burley
| Harvard University | Doctorate Degree |
| University of Oxford | Doctorate Degree |
| University of Western Ontario | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Verenigd Koninkrijk | 2 |
| Canada | 2 |
Operationeel
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 3 |
| Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC was a clinical-stage biopharmaceutical company, which focused on the development of therapeutic products for the treatment of cancer. Its product ONT-380, was an orally active and selective small-molecule HER2 inhibitor. The firm also developed preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on August 23, 1985 and was headquartered in Bothell, WA. | Health Technology |
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Health Technology |
Prospect Genomics, Inc.
Prospect Genomics, Inc. Packaged SoftwareTechnology Services Prospect Genomics, Inc. developed computational technology solutions for the pharmaceutical field. The company was headquartered in San Diego, CA. | Technology Services |
- Beurs
- Insiders
- Stephen K. Burley
- Ervaring
